History and prospects for the use of morphine in clinical practice: literature review

Abstract

The authors analyzed various studies on acute and chronic pain syndrome treatment. This review provides brief historical data on the discovery and use of morphine from ancient times to present. Morphine remains one of the most common painkillers worldwide and has a rich history dating back more than 200 years. Its basic properties, pharmacokinetics, pharmacodynamics, and principles of use are discussed. No drug has had such an impact on society as morphine because of its medical use as a pain reliever and its illicit use as a drug of addiction and abuse. This review includes the main modern recommendations for the treatment of acute and chronic pain, particularly from the World Health Organization for the treatment of chronic pain and the Procedure-Specific Postoperative Pain Management (PROSPECT) group for the treatment of postoperative pain in various surgical interventions. The types of opioids and their clinical use are described, and the authors’ opinion on the current use of morphine for treating acute and chronic pain syndrome is presented.

Keywords

morphine / history / application

References

[1] Turnaturi R, Piana S, Spoto S, et al. From Plant to Chemistry: Sources of Active Opioid Antinociceptive Principles for Medicinal Chemistry and Drug Design. Molecules. 2023;28(20):7089. doi: 10.3390/molecules28207089

[2] Turnaturi R., Piana S., Spoto S., et al. From Plant to Chemistry: Sources of Active Opioid Antinociceptive Principles for Medicinal Chemistry and Drug Design // Molecules. 2023. Vol. 28, N 20. P. 7089. doi: 10.3390/molecules28207089

[3] Tang J, Churilov L, Tan CO, et al. Intrathecal morphine is associated with reduction in postoperative opioid requirements and improvement in postoperative analgesia in patients undergoing open liver resection. BMC Anesthesiol. 2020;20(1):207. doi: 10.1186/s12871-020-01113-8

[4] Tang J., Churilov L., Tan C.O., et al. Intrathecal morphine is associated with reduction in postoperative opioid requirements and improvement in postoperative analgesia in patients undergoing open liver resection // BMC Anesthesiol. 2020. Vol. 20, N 1. P. 207. doi: 10.1186/s12871-020-01113-8

[5] Sertürner FWA. Brockhaus Encyclopedia. Mannheim: Wissen Media Verlag; 2009. (In German)

[6] Sertürner F.W.A. Brockhaus Enzyklopädie. Mannheim: Wissen Media Verlag, 2009.

[7] Klockgether-Radke AP. F.W. Sertürner and the discovery of morphine. 200 years of pain therapy with opioids. Anasthesiol Intensivmed Notfallmed Schmerzther. 2002;37(5):244–249. (In German). doi: 10.1055/s-2002-30132

[8] Klockgether-Radke A.P. F.W. Sertürner und die Entdeckung des Morphins — 200 Jahre Schmerztherapie mit Opioiden // Anasthesiol Intensivmed Notfallmed Schmerzther. 2002. Vol. 37, N 5. P. 244–249. doi: 10.1055/s-2002-30132

[9] Wicks C, Hudlicky T, Rinner U. Morphine alkaloids: History, biology, and synthesis. Alkaloids Chem Biol. 2021;(86):145–342. doi: 10.1016/bs.alkal.2021.04.001

[10] Wicks C., Hudlicky T., Rinner U. Morphine alkaloids: History, biology, and synthesis // Alkaloids Chem Biol. 2021. N 86. P. 145–342. doi: 10.1016/bs.alkal.2021.04.001

[11] Jurna I. Sertürner and morphine — a historical vignette. Schmerz. 2003;17(4):280–283. (In German). doi: 10.1007/s00482-003-0220-3

[12] Jurna I. Sertürner und Morphin — eine historische Vignette // Schmerz. 2003. Vol. 17, N 4. P. 280–283. doi: 10.1007/s00482-003-0220-3

[13] Manske RHF, Holmes HL, editors. The alkaloids: chemistry and physiology. New York: Elsevier; 2014.

[14] Manske R.H.F., Holmes H.L., editors. The alkaloids: chemistry and physiology. New York: Elsevier, 2014.

[15] Abuzarova GR, Khoronenko VE, Sarmanaeva RR. Background and perspectives of opioid analgesics for the treatment of chronic pain in cancer patients in Russia. Russian Journal of Anеsthesiology and Reanimatology. 2015;60(1):19–25. EDN: TTCHHZ

[16] Абузарова Г.Р., Хороненко В.Э., Сарманаева Р.Р. Опиоидные анальгетики для терапии хронической боли у онкологических больных в России. История вопроса и перспективы // Анестезиология и реаниматология. 2015. Т. 60, № 1. С. 19–25. EDN: TTCHHZ

[17] Bulletin on Narcotics: A Century of International Drug Control United Nations Publications. Vienna: United Nations; 2010.

[18] Bulletin on Narcotics: A Century of International Drug Control United Nations Publications. Vienna: United Nations, 2010.

[19] Goldstein A, Lowney LI, Pal BK. Stereospecific and nonspecific interactions of the morphine congener levorphanol in subcellular fractions of mouse brain. Proc Natl Acad Sci U S A. 1971;68(8):1742–1747. doi: 10.1073/pnas.68.8.1742

[20] Goldstein A., Lowney L.I., Pal B.K. Stereospecific and nonspecific interactions of the morphine congener levorphanol in subcellular fractions of mouse brain // Proc Natl Acad Sci U S A. 1971. Vol. 68, N 8. P. 1742–1747. doi: 10.1073/pnas.68.8.1742

[21] Pert CB, Snyder SH. Opiate receptor: demonstration in nervous tissue. Science. 1973;179(4077):1011–1014. doi: 10.1126/science.179.4077.1011

[22] Pert C.B., Snyder S.H. Opiate receptor: demonstration in nervous tissue // Science. 1973. Vol. 179, N 4077. P. 1011–1014. doi: 10.1126/science.179.4077.1011

[23] Davis MP, Walsh D. Methadone for relief of cancer pain: a review of pharmacokinetics, pharmacodynamics, drug interactions and protocols of administration. Support Care Cancer. 2001;9(2):73−83. doi: 10.1007/s005200000180

[24] Davis M.P., Walsh D. Methadone for relief of cancer pain: a review of pharmacokinetics, pharmacodynamics, drug interactions and protocols of administration // Support Care Cancer. 2001. Vol. 9. P. 73−83. doi: 10.1007/s005200000180

[25] Rezaei M, Naghavi MR, Hosseinzadeh A, et al. Spatiotemporal oscillations of morphinan alkaloids in opium poppy. J Biosci. 2018;43(2):391–405.

[26] Rezaei M., Naghavi M.R., Hosseinzadeh A., et al. Spatiotemporal oscillations of morphinan alkaloids in opium poppy // J Biosci. 2018. Vol. 43, N 2. P. 391–405.

[27] Rinner U, Hudlicky T. Synthesis of morphine alkaloids and derivatives. Top Curr Chem. 2012;(309):33–66. doi: 10.1007/128_2011_133

[28] Rinner U., Hudlicky T. Synthesis of morphine alkaloids and derivatives // Top Curr Chem. 2012. N 309. P. 33–66. doi: 10.1007/128_2011_133

[29] Jacobsen LS, Olsen AK, Sjøgren P, Jensen NH. Morphine-induced hyperalgesia, allodynia and myoclonus — new side-effects of morphine? Ugeskr Laeger. 1995;157(23):3307–3310. (In Danish)

[30] Jacobsen L.S., Olsen A.K., Sjøgren P., Jensen N.H. Morfininduceret hyperalgesi, allodyni og myoklonus — nye morfinbivirkninger? // Ugeskr Laeger. 1995. Vol. 157, N 23. P. 3307–3310.

[31] Vanegas G, Ripamonti C, Sbanotto A, De Conno F. Side effects of morphine administration in cancer patients. Cancer Nurs. 1998;21(4):289–297. doi: 10.1097/00002820-199808000-00011

[32] Vanegas G., Ripamonti C., Sbanotto A., De Conno F. Side effects of morphine administration in cancer patients // Cancer Nurs. 1998. Vol. 21, N 4. P. 289–297. doi: 10.1097/00002820-199808000-00011

[33] O’Neill A, Lirk P. Multimodal Analgesia. Anesthesiol Clin. 2022;40(3):455–468. doi: 10.1016/j.anclin.2022.04.002

[34] O’Neill A., Lirk P. Multimodal Analgesia // Anesthesiol Clin. 2022. Vol. 40, N 3. P. 455–468. doi: 10.1016/j.anclin.2022.04.002

[35] PROSPECT [Internet]. ESRA Europe; 2002–2024 [cited 2024 Feb 4]. Available from: https://esraeurope.org/pain-management/

[36] PROSPECT [Internet]. ESRA Europe; 2002–2024. Режим доступа: https://esraeurope.org/pain-management/. Дата обращения: 04.02.2024.

[37] Chalil A, Staudt MD, Harland TA, et al. A safety review of approved intrathecal analgesics for chronic pain management. Expert Opin Drug Saf. 2021;20(4):439–451. doi: 10.1080/14740338.2021.1889513

[38] Chalil A., Staudt M.D., Harland T.A., et al. A safety review of approved intrathecal analgesics for chronic pain management // Expert Opin Drug Saf. 2021. Vol. 20, N 4. P. 439–451. doi: 10.1080/14740338.2021.1889513

[39] Laux-Biehlmann A, Mouheiche J, Vérièpe J, Goumon Y. Endogenous morphine and its metabolites in mammals: history, synthesis, localization and perspectives. Neuroscience. 2013;(233):95–117. doi: 10.1016/j.neuroscience.2012.12.013

[40] Laux-Biehlmann A., Mouheiche J., Vérièpe J., Goumon Y. Endogenous morphine and its metabolites in mammals: history, synthesis, localization and perspectives // Neuroscience. 2013. N 233. P. 95–117. doi: 10.1016/j.neuroscience.2012.12.013

[41] Morphine Liposomal — SkyePharma: C 0401, D 0401, morphine — DepoFoam, SKY 0401. Drugs R D. 2003;4(6):373–375. doi: 10.2165/00126839-200304060-00009

[42] Morphine Liposomal — SkyePharma: C 0401, D 0401, morphine — DepoFoam, SKY 0401 // Drugs R D. 2003. Vol. 4, N 6. P. 373–375. doi: 10.2165/00126839-200304060-00009

[43] Cooper TE, Chen J, Wiffen PJ, et al. Morphine for chronic neuropathic pain in adults. Cochrane Database Syst Rev. 2017;5(5):CD011669. doi: 10.1002/14651858.CD011669.pub2

[44] Cooper T.E., Chen J., Wiffen P.J., et al. Morphine for chronic neuropathic pain in adults // Cochrane Database Syst Rev. 2017. Vol. 5, N 5. CD011669. doi: 10.1002/14651858.CD011669.pub2

[45] Hanks GW. Morphine pharmacokinetics and analgesia after oral administration. Postgrad Med J. 1991;67(Suppl 2):S60–S63.

[46] Hanks G.W. Morphine pharmacokinetics and analgesia after oral administration // Postgrad Med J. 1991. Vol. 67, Suppl. 2. P. S60–S63.

[47] Kullmann T, Sipőcz I, Csikós Á, Pintér T. New option in the management of cancer pain in Hungary: short acting oral opioid therapy. Orv Hetil. 2015;156(25):1003–1006. (In Hungarian). doi: 10.1556/650.2015.30171

[48] Kullmann T., Sipőcz I., Csikós Á., Pintér T. Új lehetőség a daganatos fájdalom csillapításában Magyarországon: rövid hatású major analgetikumok // Orv Hetil. 2015. Vol. 156, N 25. P. 1003–1006. doi: 10.1556/650.2015.30171

[49] Deer TR, Pope JE, Hayek SM, et al. The Polyanalgesic Consensus Conference (PACC): Recommendations on Intrathecal Drug Infusion Systems Best Practices and Guidelines. Neuromodulation. 2017;20(2):96–132. doi: 10.1111/ner.12538. Erratum in: Neuromodulation. 2017;20(4):405–406.

[50] Deer T.R., Pope J.E., Hayek S.M., et al. The Polyanalgesic Consensus Conference (PACC): Recommendations on Intrathecal Drug Infusion Systems Best Practices and Guidelines // Neuromodulation. 2017. Vol. 20, N 2. P. 96–132. doi: 10.1111/ner.12538. Erratum in: Neuromodulation. 2017. Vol. 20, N 4. P. 405–406.

[51] Deer TR, Pope JE, Hanes MC, McDowell GC. Intrathecal Therapy for Chronic Pain: A Review of Morphine and Ziconotide as Firstline Options. Pain Med. 2019;20(4):784–798. doi: 10.1093/pm/pny132

[52] Deer T.R., Pope J.E., Hanes M.C, McDowell GC. Intrathecal Therapy for Chronic Pain: A Review of Morphine and Ziconotide as Firstline Options // Pain Med. 2019. Vol. 20, N 4. P. 784–798. doi: 10.1093/pm/pny132

[53] Yiping S, Jiayi S, Guang H, et al. The efficacy and safety of epidural morphine / hydromorphone in the treatment of intractable postherpetic neuralgia: A single-center, double-blinded, randomized controlled, prospective, and non-inferiority study. Front Pharmacol. 2022;(13):1051357. doi: 10.3389/fphar.2022.1051357

[54] Yiping S., Jiayi S., Guang H., et al. The efficacy and safety of epidural morphine / hydromorphone in the treatment of intractable postherpetic neuralgia: A single-center, double-blinded, randomized controlled, prospective, and non-inferiority study // Front Pharmacol. 2022. N 13. P. 1051357. doi: 10.3389/fphar.2022.1051357

[55] Tang CY, Tu YK, Kao MC, et al. Effects of opioids administered via intravenous or epidural patient-controlled analgesia after caesarean section: A network meta-analysis of randomised controlled trials. EClinicalMedicine. 2022;(56):101787. doi: 10.1016/j.eclinm.2022.101787

[56] Tang C.Y., Tu Y.K., Kao M.C., et al. Effects of opioids administered via intravenous or epidural patient-controlled analgesia after caesarean section: A network meta-analysis of randomised controlled trials // EClinicalMedicine. 2022. N 56. P. 101787. doi: 10.1016/j.eclinm.2022.101787

[57] Roofthooft E, Joshi GP, Rawal N, et al. PROSPECT guideline for elective caesarean section: updated systematic review and procedure-specific postoperative pain management recommendations. Anaesthesia. 2021;76(5):665–680. doi: 10.1111/anae.15339

[58] Roofthooft E., Joshi G.P., Rawal N., et al. PROSPECT guideline for elective caesarean section: updated systematic review and procedure-specific postoperative pain management recommendations // Anaesthesia. 2021. Vol. 76, N 5. P. 665–680. doi: 10.1111/anae.15339

[59] Yen D, Turner K, Mark D. Is a single low dose of intrathecal morphine a useful adjunct to patient-controlled analgesia for postoperative pain control following lumbar spine surgery? A preliminary report. Pain Res Manag. 2015;20(3):129–132. doi: 10.1155/2015/761390

[60] Yen D., Turner K., Mark D. Is a single low dose of intrathecal morphine a useful adjunct to patient-controlled analgesia for postoperative pain control following lumbar spine surgery? A preliminary report // Pain Res Manag. 2015. Vol. 20, N 3. P. 129–132. doi: 10.1155/2015/761390

[61] Bang YJ, Lee EK, Kim CS, et al. The Effect of Intrathecal Morphine on Postoperative Opioid Consumption in Patients Undergoing Abdominal Surgery for Gynecologic Malignancy: A Randomized Sham-Controlled Trial. Anesth Analg. 2023;137(3):525–533. doi: 10.1213/ANE.0000000000006358

[62] Bang Y.J., Lee E.K., Kim C.S., et al. The Effect of Intrathecal Morphine on Postoperative Opioid Consumption in Patients Undergoing Abdominal Surgery for Gynecologic Malignancy: A Randomized Sham-Controlled Trial // Anesth Analg. 2023. Vol. 137, N 3. P. 525–533. doi: 10.1213/ANE.0000000000006358

RIGHTS & PERMISSIONS

Eco-Vector